In 51 adults with treated coeliac disease given blinded gluten (1–1000 mg) or placebo challenges, serum IL2 doubled in 83% at 1000 mg and 17% at 3 mg, none at ≤2 mg or placebo; estimated ED10 was 2.4 mg. Symptoms did not rise beyond placebo.
RCTn = 51
Daveson et al. A Randomized Double-Blind, Placebo-Controlled Dose-Response Study to Assess the Gluten Threshold Dose in Celiac Disease